A new combination of three drugs that harness the body’s immune system is safe and effective, destroying most cancer cells in 95 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study. Presented Dec. 3 at the annual meeting of the American Society of Hematology in San Diego, the study in 19 men and women […]

Continue reading »